Integrated diagnosis and treatment for chronic kidney disease outcomes
A Prospective, Cohort, and Observational Study of the Effect of Integrated Diagnosis and Treatment of Chronic Kidney Disease (CKD) on Clinical Outcomes in Real World Clinical Practice
Capital Medical University · NCT05242055
This study is trying to see if a combined approach to diagnosing and treating chronic kidney disease can help patients manage their health better and improve their overall outcomes.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 1000 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | All |
| Sponsor | Capital Medical University (other) |
| Locations | 1 site (Beijing, Beijing Municipality) |
| Trial ID | NCT05242055 on ClinicalTrials.gov |
What this trial studies
This observational study aims to establish a cohort of 1000 patients with chronic kidney disease (CKD) to evaluate the effectiveness of integrated diagnosis and treatment approaches in a real-world setting. Participants will undergo regular monitoring and management of various health parameters, including blood pressure, blood glucose, and anemia, while receiving guidance on diet and exercise. The study will also analyze the clinical prognosis of patients based on different risk stratifications and identify factors associated with cardiovascular disease outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 and older who are at risk of developing chronic kidney disease.
Not a fit: Patients under 18 years old, those unable to comply with study procedures, or those with an estimated follow-up time of less than 6 months may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved management strategies for patients with chronic kidney disease, potentially enhancing their overall health outcomes.
How similar studies have performed: Other studies have shown success with integrated management approaches for chronic diseases, suggesting potential for positive outcomes in this study as well.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * ≥18 years old; * Voluntarily signed informed consent; * Patients who are estimated to develop CKD. Exclusion Criteria: * Age \< 18 or ≥100 years; * Unable to comply with the procedures stipulated in this study; * Estimated follow-up time ≤6 months.
Where this trial is running
Beijing, Beijing Municipality
- Nephrology Department of Beijing Jishuitan Hospital — Beijing, Beijing Municipality, China (RECRUITING)
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Chronic Kidney Diseases, Hypertension, Hyperglycemia, Hyperlipidemias, Anemia, Chronic Kidney Disease-Mineral and Bone Disorder, Malnutrition